You are about to leave the Clinical Value website now.


ESMO 2023 Madrid – Shaping the Future of Personalised Healthcare for Cancer Patients

Missed the satellite symposium sessions from ESMO 2023? Access the programme details and webcast recording here. …

APAC Oncology Summit 2023 Webinar

NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff

In this article, Prof Peter Gibbs and Prof Svetlana Cherepanoff discuss the issues surrounding the clinical integration of NGS in Australia….

NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh

NGS and digital applications for oncology management can help improve early cancer detection and prevention, reducing human and economic costs of the cancer. In this article, Dr Jan-Gowth Chang and Dr Jason CH Hsieh explore the current use of these technologies in Taiwan and their hopes for the future. …

NGS and precision oncology in India: insights from Dr Amit Rauthan

In this article, Dr Amit Rauthan shares insights on the challenges and opportunities for greater NGS adoption in India. …

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

This study proposes a unified framework to classify targets for precision cancer medicine based on clinical evidence of utility, to aid oncologists in prioritising potential targets for clinical use when receiving reports of broad gene sequencing panels, and facilitate implementation of precision medicine in the clinical management of cancer….